Dear colleagues!
after exciting ASH 2021 and EHA 2022 annual congresses and fundamental updates in the field of DLBCL, the idea was born to organize a preceptorship-meeting at University Hospital Würzburg (UKW). German and international colleagues discussed the changed DLBCL landscape and arising implications. Our main scientific objectives were:
- Discussion of the updated DLBCL treatment landscape
- Exchange of “hands on experience” regarding novel therapies under peers
- Increase of awareness of novel treatment-sequencing modalities within the community.
We are happy to let you re-live the meeting via our on-demand videos
Best regards,
Johannes Düll, Senior physician
Universitätsklinik Würzburg
Dr. med. Johannes Düll
Prof. Dr. med. Andreas Rosenwald
Professor Gilles Salles
Prof. Dr. med. Andreas Buck
Prof. Dr. med. Peter Borchmann
Dr. med. Johannes Düll
– From R-GemOx to CAR T
Prof. Dr. med. Max Topp
Prof. Dr. med. Georg Lenz
Prof. Dr. med. Björn Chapuy
Anna Ruckdeschel
